{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-058621","form_type":"8-K","ticker":"UNCY","cik":"0001766140","company_name":"Unicycive Therapeutics, Inc.","filed_at":"2024-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.456144+00:00","generated_at":"2026-05-31T23:48:20.266413+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Unicycive amends OLC manufacturing deal with Shilpa, secures binding purchase order","bullets":["Binding purchase order for OLC tablets; delivery by June 30, 2025.","Additional OLC tablet orders required between Dec 31, 2025 and June 30, 2026.","Company to provide funding to Shilpa for a new manufacturing line.","Initial term extended to 8th anniversary of FDA approval of OLC NDA."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-058621","json":"https://secwatch.observer/filing/0001213900-24-058621.json","markdown":"https://secwatch.observer/filing/0001213900-24-058621.md","text":"https://secwatch.observer/filing/0001213900-24-058621.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766140/000121390024058621/0001213900-24-058621-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766140/000121390024058621/ea0208854-8k_unicycive.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:48:20.266413+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}